Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	* patients not vaccinated against covid-19 vaccination. * patients who received heterologous first two doses of vaccine * patients with a severe allergic reaction to prior covid-19 vaccination or any of the ingredients. * new covid-19 infection	* patients not vaccinated against covid-19 vaccination. * patients who received heterologous first two doses of vaccine * patients with a severe allergic reaction to prior covid-19 vaccination or any of the ingredients. * new covid-19 infection
Sept. 28, 2021, 8 a.m.	usa	- patients not vaccinated against covid-19 vaccination. - patients who received heterologous first two doses of vaccine - patients with a severe allergic reaction to prior covid-19 vaccination or any of the ingredients. - new covid-19 infection	- patients not vaccinated against covid-19 vaccination. - patients who received heterologous first two doses of vaccine - patients with a severe allergic reaction to prior covid-19 vaccination or any of the ingredients. - new covid-19 infection
Aug. 27, 2021, 8 p.m.	usa	- patients not vaccinated against covid-19 vaccination. - patients who received heterologous first two doses of vaccine (expected to be a minimal number in this population as almost all patients received the same vaccine for both doses due to vaccination in dialysis units). - patients with a severe allergic reaction to prior covid-19 vaccination or any of the ingredients. - new covid-19 infection following study enrolment	- patients not vaccinated against covid-19 vaccination. - patients who received heterologous first two doses of vaccine (expected to be a minimal number in this population as almost all patients received the same vaccine for both doses due to vaccination in dialysis units). - patients with a severe allergic reaction to prior covid-19 vaccination or any of the ingredients. - new covid-19 infection following study enrolment